Back to results
US 12,304,968 B2Granted
T-cells expressing anti-LIV1 chimeric antigen receptor
AssigneeCrispr Therapeutics AG
InventorsJonathan Alexander Terrett, Jason Sagert
Life of this patent
Estimating the term…
Abstract
Provided herein, in some embodiments, are methods and compositions (e.g., cell compositions) for the treatment of cancer, such as LIV1+ malignancies.
Claims12
An engineered T cell comprising a nucleic acid encoding a chimeric antigen receptor (CAR) encoded by the nucleotide sequence of any one of SEQ ID NOs:
- 49, 51, 104, and 108.
Dependencies are inferred from the claim text.